Book contents
- Bipolar II Disorder
- Bipolar II Disorder
- Copyright page
- Dedication
- Contents
- Contributors
- Preface to the Third Edition
- Acknowledgements
- Section 1 Domain Chapters
- Section 2 Management Commentaries
- 18 Introduction to Management Commentaries
- 19 Management Commentary
- 20 Management Commentary
- 21 Management Commentary
- 22 Management Commentary
- 23 Management Commentary
- 24 Management Commentary
- 25 Management Commentary
- 26 Management Commentary
- 27 Management Commentary
- 28 Management Commentary
- 29 Management Commentary
- 30 Management Commentary
- 31 Management Commentary
- 32 Management Commentary
- 33 Management commentary
- 34 Management Commentary
- 35 Management Commentary
- 36 Management Commentary
- Section 3 Conclusion
- Index
- References
22 - Management Commentary
from Section 2 - Management Commentaries
Published online by Cambridge University Press: 17 December 2018
Edited by
Book contents
- Bipolar II Disorder
- Bipolar II Disorder
- Copyright page
- Dedication
- Contents
- Contributors
- Preface to the Third Edition
- Acknowledgements
- Section 1 Domain Chapters
- Section 2 Management Commentaries
- 18 Introduction to Management Commentaries
- 19 Management Commentary
- 20 Management Commentary
- 21 Management Commentary
- 22 Management Commentary
- 23 Management Commentary
- 24 Management Commentary
- 25 Management Commentary
- 26 Management Commentary
- 27 Management Commentary
- 28 Management Commentary
- 29 Management Commentary
- 30 Management Commentary
- 31 Management Commentary
- 32 Management Commentary
- 33 Management commentary
- 34 Management Commentary
- 35 Management Commentary
- 36 Management Commentary
- Section 3 Conclusion
- Index
- References
- Type
- Chapter
- Information
- Bipolar II DisorderModelling, Measuring and Managing, pp. 225 - 230Publisher: Cambridge University PressPrint publication year: 2019
References
Dierckx, B., Heijnen, W.T., van den Broek, W.W. et al., (2012). Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: a meta‐analysis. Bipolar Disorders, 14, 146–50.Google Scholar
Lydiard, R.B., Culpepper, L., Schiöler, H. et al., (2009). Quetiapine monotherapy as treatment for anxiety symptoms in patients with bipolar depression: a pooled analysis of results from 2 double-blind, randomized, placebo-controlled studies. Primary Care Companion to the Journal of Clinical Psychiatry, 11, 215.CrossRefGoogle ScholarPubMed
McElroy, S.L., Weisler, R.H., Chang, W. et al., (2010). A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression. Journal of Clinical Psychiatry, 71, 163.Google Scholar
McIntyre, R.S., Cucchiaro, J., Pikalov, A. et al., (2015). Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial. Journal of Clinical Psychiatry, 76, 398–405.Google Scholar
Scott, J., Paykel, E., Morriss, R. et al., (2006). Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. British Journal of Psychiatry, 188, 313–20.Google Scholar
Sheehan, D.V., Harnett-Sheehan, K., Hidalgo, R.B. et al., (2013). Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient. Journal of Affective Disorders, 145, 83–94.Google Scholar
Sikdar, S., Kulhara, P., Avasthi, A. et al., (1994). Combined chlorpromazine and electroconvulsive therapy in mania. British Journal of Psychiatry, 164, 806–10.Google Scholar
Suppes, T., Silva, R., Cucchiaro, J. et al., (2015). Lurasidone for the treatment of major depressive disorder with mixed features: a randomized, double-blind, placebo-controlled study. American Journal of Psychiatry, 173, 400–7.Google Scholar
Swartz, H.A. and Thase, M.E. (2011). Pharmacotherapy for the treatment of acute bipolar II depression: current evidence. Journal of Clinical Psychiatry, 72, 356.Google Scholar
Young, A.H., McElroy, S.L., Bauer, M. et al., (2010). A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). Journal of Clinical Psychiatry, 71, 150–62.Google ScholarPubMed